2025 PACC Miami | Revumenib and the Rise of Menin Inhibitors: A New Era in AML
Overview
NA
Target Audience
Pharmacists
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Nicole Bentivegna, PharmD, BCOP
Date of Release
November 23rd, 2025
-1763851572878.webp&w=3840&q=75)
-1763851492821.webp&w=3840&q=75)